Our top pick for
Utz Brands Inc is a packaged foods business based in the US. Utz Brands shares (UTZ) are listed on the NYSE and all prices are listed in US Dollars. Utz Brands employs 3,083 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$15.40|
|52-week range||$15.05 - $30.02|
|50-day moving average||$17.79|
|200-day moving average||$22.13|
|Wall St. target price||$22.56|
|Dividend yield||$0.21 (1.3%)|
|Earnings per share (TTM)||$-1.60|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-4.05%|
|1 month (2021-09-23)||-14.11%|
|3 months (2021-07-23)||-32.90%|
|6 months (2021-04-23)||-43.71%|
|1 year (2020-10-23)||-12.90%|
|2 years (2019-10-23)||51.13%|
|3 years (2018-10-19)||N/A|
|5 years (2016-10-19)||N/A|
Valuing Utz Brands stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Utz Brands's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Utz Brands's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $88.5 million.
The EBITDA is a measure of a Utz Brands's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.1 billion|
|Operating margin TTM||2.18%|
|Gross profit TTM||$338.5 million|
|Return on assets TTM||0.93%|
|Return on equity TTM||-16.16%|
|Market capitalisation||$2.2 billion|
TTM: trailing 12 months
There are currently 5.5 million Utz Brands shares held short by investors – that's known as Utz Brands's "short interest". This figure is 13.4% up from 4.8 million last month.
There are a few different ways that this level of interest in shorting Utz Brands shares can be evaluated.
Utz Brands's "short interest ratio" (SIR) is the quantity of Utz Brands shares currently shorted divided by the average quantity of Utz Brands shares traded daily (recently around 623038.95216401). Utz Brands's SIR currently stands at 8.78. In other words for every 100,000 Utz Brands shares traded daily on the market, roughly 8780 shares are currently held short.
However Utz Brands's short interest can also be evaluated against the total number of Utz Brands shares, or, against the total number of tradable Utz Brands shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Utz Brands's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Utz Brands shares in existence, roughly 40 shares are currently held short) or 0.089% of the tradable shares (for every 100,000 tradable Utz Brands shares, roughly 89 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Utz Brands.
Find out more about how you can short Utz Brands stock.
Dividend payout ratio: 28.16% of net profits
Recently Utz Brands has paid out, on average, around 28.16% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.24% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Utz Brands shareholders could enjoy a 1.24% return on their shares, in the form of dividend payments. In Utz Brands's case, that would currently equate to about $0.21 per share.
While Utz Brands's payout ratio might seem fairly standard, it's worth remembering that Utz Brands may be investing much of the rest of its net profits in future growth.
Utz Brands's most recent dividend payout was on 10 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 16 September 2021 (the "ex-dividend date").
Over the last 12 months, Utz Brands's shares have ranged in value from as little as $15.05 up to $30.0247. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Utz Brands's is 0.6939. This would suggest that Utz Brands's shares are less volatile than average (for this exchange).
Utz Brands, Inc. operates as a snack food manufacturing company. It offers a range of salty snacks, including potato chips, pretzels, cheese snacks, veggie snacks, pork skins, pub/party mixes, and other snacks under the Utz, Zapp's, ON THE BORDER, Golden Flake, Good Health, Boulder Canyon, Hawaiian, and TORTIYAHS brands. The company distributes its products through grocery, mass, club, convenience, drug, and other retailers. The company was formerly known as Collier Creek Holdings and changed its name to Utz Brands, Inc. in August 2020. Utz Brands, Inc.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.